Lessons Learned in the Development of De-Implementation Strategies to Address Mammography Overscreening Among Older.

Rachel Shelton, ScD, MPH and Nathalie Moise, MD, MS | February 11, 2025 : There is a need and opportunity to advance the science of de-implementation. Mammography screening among women 75 and older presents a robust area for inquiry related to de-implementation, as routine screening can lead to potential harms (e.g., overdiagnosis, overtreatment) while health benefits…

Read More

The Longitudinal Implementation Strategy Tracking System (LISTS): Lessons Learned from Applying the Method and New Online Tool

JD Smith, PhD and James Merle, PhD | February 18, 2025 : Documenting and tracking the dynamic changes to implementation strategies over time is crucial for advancing implementation science. Several methods for tracking strategies have been proposed recently, underscoring the importance of continued development of methods to accurately assess and monitor which strategies are used,…

Read More

Methadone Patient Access to Collaborative Treatment (MPACT)

Beth Meyerson, MDiv, PhD | February 4, 2025 : Methadone Patient Access to Collaborative Treatment (MPACT) is an experimental, multimodal intervention for methadone clinic staff and funded by NIDA. This presentation will provide a brief overview of MPACT, discuss the planned hybrid trial (late fall 2025), the village that collaboratively developed MPACT and the importance…

Read More

The Buprenorphine Prescribing Support Program for Rural Primary Care

Berkeley Franz, PhD | January 28, 2025: Buprenorphine is a critical tool to prevent overdose and infectious disease transmission in people with opioid use disorder, but it is difficult to access in rural areas. A promising solution is to engage rural primary care professionals. But the willingness of primary care professionals to prescribe this medication presents…

Read More

Revisiting Concepts of Evidence in Implementation Science

Ross Brownson, PhD | January 14, 2025 : Evidence, in multiple forms, is a foundation of implementation research. For public health and clinical practice, evidence includes: Type 1 evidence on etiology and burden; Type 2 evidence on effectiveness of interventions; and Type 3: evidence on dissemination and implementation within context. Because current concepts of evidence…

Read More

Costing and Payment Tools in Addiction Research to Support Effective Dissemination of Economic Evidence

Kathryn McCollister, PhD | December 3, 2024 : Recent studies of the costs and economic impact of interventions for substance use disorder (SUD) have led to the development of costing tools and reimbursement calculators that support cost-effectiveness and cost-offset analyses and provide payers and other stakeholders with tailored products to assess budget impact and financial…

Read More

Understanding the Impact of Discrimination on Substance Use Among Black Justice-Involved Youth: A NIDA K23 Study

Brittany Bryant, DSW, LCSW-CP/S | November 19, 202 : Substance use among Black justice-involved youth is a critical public health issue, often exacerbated by experiences of discrimination and systemic racism. This NIDA K23 study aims to investigate the complex relationship between discrimination and substance use within this vulnerable population. Through qualitative interviews, the study will…

Read More